20th IMS Annual Meeting
Mark your calendar for the upcoming IMS Annual Meeting!
Join us in Athens, Greece from September 27-30, 2023 for the 20th International Myeloma Society Annual Meeting and Exposition! Watch the video below for a sneak peek of what Athens has to offer. |
Our sponsors:
Titanium
Platinum
Gold
Bronze
Practical Insights in Novel Immune Therapies in Multiple Myeloma Workshop
Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this workshop is for you!
This high-impact educational program, held in conjunction with the DGHO Annual Meeting, seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals
Our sponsors:
5th Immune Effector Cell Therapies in Multiple Myeloma Workshop
IMS is pleased to announce that the 5th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 23-24, 2024 in Boston, MA.
Our sponsors:
Titanium
Practical Insights in Novel Immune Therapies in Multiple Myeloma Webinar – East Coast
Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this 90-minute webinar is for you!
This high-impact, 90-minute educational program seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.
Educational Workshop, Buenos Aires, Argentina
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Practical Insights in Novel Immune Therapies in Multiple Myeloma Webinar – West Coast
Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this 90-minute webinar is for you!
This high-impact, 90-minute educational program seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
